Quantum Biopharma購買了價值100萬美元的比特幣和其他加密貨幣

根據5月19日的新聞稿，該購買的價格將Quantum的總加密貨幣持有量達到約450萬美元。

Canadian biotechnology company Quantum Biopharma has purchased an additional $1 million worth of Bitcoin and other cryptocurrencies.

加拿大生物技術公司Quantum Biopharma購買了價值100萬美元的比特幣和其他加密貨幣。

The buys take Quantum’s total cryptocurrency holdings to approximately $4.5 million, according to a May 19 announcement. The biotech company plans to stake a portion of its crypto to generate revenue.

根據5月19日的公告，該購買的價格將Quantum的總加密貨幣持有量達到約450萬美元。這家生物技術公司計劃將一部分加密貨幣存儲以產生收入。

Quantum expects that holding a treasury of Bitcoin (BTC) and other crypto assets will “provide a return on investment for shareholders and […] provide some hedge against the Canadian dollar,” it said.

Quantum預計，持有比特幣（BTC）的國庫，而其他加密資產將“為股東提供投資回報，[…]對加拿大美元提供了對沖，”它說。

Shares of Quantum’s stock, QNTM, rose by approximately 25% following the announcement, according to data from Google Finance.

根據Google Finance的數據，宣布這一消息後，量子股票QNTM的股票增長了約25％。

Related: Basel Medical shares down 15% on $1B Bitcoin buying plans

相關：巴塞爾醫療股價下跌了15％，$ 1B比特幣購買計劃

Quantum is one of several healthcare companies accumulating Bitcoin as corporate crypto treasuries become increasingly popular.

隨著公司加密庫庫變得越來越流行，量子是積累比特幣的幾家醫療保健公司之一。

In March, NASDAQ-listed biopharmaceutical company Atai Life Sciences tipped plans to buy $5 million worth of Bitcoin.

3月，納斯達克上市的生物製藥公司Atai Life Sciences提出了購買價值500萬美元的比特幣的計劃。

In a March 20 X post, Atai’s founder, Christian Angermayer, said “Bitcoin should be a part of ANY corporate treasury – especially, in fact, in the biotech sector.”

Atai的創始人Christian Angermayer在3月20日的帖子中說：“比特幣應該是任何公司財政部的一部分，尤其是實際上，在生物技術領域。”

Angermayer added in a blog post that Bitcoin can help the biotech hedge against inflation and stay solvent during the long periods before drug approvals.

Angermayer在博客文章中補充說，比特幣可以幫助生物技術對沖通貨膨脹，並在毒品批准之前長期保持溶劑。

On May 16, Singapore-based healthcare company Basel Medical Group announced plans to buy $1 billion worth of Bitcoin.

5月16日，總部位於新加坡的醫療保健公司巴塞爾醫療集團（Basel Medical Group）宣布計劃購買價值10億美元的比特幣。

It said a Bitcoin treasury will support its plans to expand in Asia through acquisitions by giving Basel “one of the strongest balance sheets among Asia-focused healthcare providers.”

它說，比特幣財政部將通過收購來支持其在亞洲擴展的計劃，這是巴塞爾“以亞洲為中心的醫療保健提供者中最強大的資產負債表之一”。

Unlike Quantum, however, Basel’s shares dropped significantly on the day of the announcement.

但是，與Quantum不同，巴塞爾的股票在宣布當天大幅下降。

Collectively, corporate treasuries hold more than $83 billion in Bitcoin as of May 19, according to data from BitcoinTreasuries.NET.

根據BitCoinReasuries.net的數據，截至5月19日，企業庫庫截至5月19日持有超過830億美元的比特幣。

Publicly traded companies are now the largest institutional Bitcoin holders after exchange-traded funds (ETFs), the data shows.

數據顯示，公開交易的公司現在是交易所交易基金（ETF）之後最大的機構比特幣持有者。

Bitcoin can “potentially be a valuable hedge against growing fiscal deficits, currency debasement, and geopolitical risks” for companies, asset manager Fidelity Digital Assets said in a 2024 report.

資產經理Fidelity Digital Assets在2024年的一份報告中說，比特幣“有可能成為不斷增長的財政缺陷，貨幣貶低和地緣政治風險的寶貴對沖”。